Forte Biosciences, Inc. (FBRX)

76.95 0.00 (0.00%) USD  |  NASDAQ  |  Aug 25, 12:32
More

Forte Biosciences EPS Estimates for Next Quarter

EPS Estimates for Next Quarter Chart

View EPS Estimates for Next Quarter for FBRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Quarter Chart
Start Trial

Historical EPS Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 13, 2026 --
July 27, 2026 --
July 21, 2026 --
July 09, 2026 --
May 13, 2026 --
May 11, 2026 --
April 06, 2026 --
April 02, 2026 --
April 01, 2026 --
March 31, 2026 --
February 20, 2026 --
January 19, 2026 --
November 14, 2025 --
August 18, 2025 --
August 16, 2025 --
August 15, 2025 --
Date Value
June 30, 2025 --
June 24, 2025 --
June 05, 2025 --
May 16, 2025 --
May 15, 2025 --
April 03, 2025 --
April 01, 2025 --
March 31, 2025 --
February 21, 2025 --
January 21, 2025 --
September 03, 2024 --
August 19, 2024 --
August 15, 2024 --
May 29, 2024 --
April 08, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Quarter Range, Past 5 Years

View EPS Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Quarter Benchmarks

View EPS Estimates for Next Quarter Benchmarks
Start Trial
argenx SE Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade

EPS Estimates for Next Quarter Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade